Nutex Health (NUTX) Payables (2010 - 2026)

Nutex Health has reported Payables for 17 years, with the latest figure at $46.5 million in Q1 2026.

• Quarterly Payables rose 1427.2% year-over-year to $46.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $46.5 million (up 1427.2% YoY) and the FY2025 annual result came in at $3.1 million, down 67.71% from the prior year.
• Payables grew to $46.5 million in Q1 2026 per NUTX's latest filing, from $3.1 million in the prior quarter.
• Over five years, Payables peaked at $46.5 million in Q1 2026 and troughed at -$3.5 million in Q1 2025.
• A 5-year average of $14.0 million and a median of $9.6 million in 2024 frame the typical range for Payables.
• The widest YoY moves for Payables: up 22637.5% in 2025, down 450.0% in 2025.
• Over 5 years, Payables stood at $4.0 million in 2022, then slumped by 65.14% to $1.4 million in 2023, then soared by 586.71% to $9.6 million in 2024, then tumbled by 67.71% to $3.1 million in 2025, then jumped by 1396.52% to $46.5 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $46.5 million, $3.1 million, and $45.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.